A chronic, relapsing condition in which excess body fat raises the risk of other disease. Roughly one in eight people worldwide now lives with obesity1. The biology that defends body weight is powerful and well described, which is why this is treated as a medical condition rather than a matter of resolve.
Last updated:
Excess adipose tissue in an amount that harms health. The important word is adipose, because the problem is what fat tissue does hormonally and inflammatorily, not what a body looks like.
Where that fat sits matters more than how much of it there is. Subcutaneous fat, the layer under the skin, is comparatively inert. Visceral fat, packed around the liver, pancreas and intestines, behaves like an active endocrine organ: it releases inflammatory signals and free fatty acids straight into the portal circulation, which is the route by which it drives insulin resistance, raises blood pressure and pushes fat into the liver.
That is why two people at the same weight can have very different metabolic risk, and why a tape measure around the waist often tells you more than the number on a scale.
Adipose tissue is an endocrine organ. As it expands it releases inflammatory signals and free fatty acids that drive insulin resistance, raise blood pressure and push fat into the liver.
BMI is a population screening tool. It cannot distinguish muscle from fat or say where fat sits, and it performs differently across ethnic groups. It is a starting point for a conversation, not a diagnosis.
Genetics, sleep, medication, the food environment, socioeconomic constraint and previous dieting all shift the level a body settles at. Two people eating identically do not arrive at the same place.
Obesity is usually identified by measurement rather than by symptoms. What follows are the conditions it raises the risk of, and the signs worth acting on.
Type 2 diabetes, high blood pressure, raised triglycerides and low HDL, and fatty liver. Weight loss of 5 to 10% measurably improves blood pressure, triglycerides and glycaemic control3, and substantial weight loss can put type 2 diabetes into remission4.
Obstructive sleep apnea is common and frequently undiagnosed. Loud snoring, witnessed pauses in breathing, unrefreshing sleep and daytime sleepiness are worth raising with your doctor, because treating it improves blood pressure, mood and daytime function.
Load-bearing joints, particularly knees, carry a multiple of body weight with each step. Pain limits activity, and reduced activity compounds the problem, which is why keeping movement tolerable matters more than making it intense.
Depression and obesity each raise the risk of the other. In a large trial of intensive lifestyle change, participants improved on depression scores, sleep apnea, mobility and physical function5, and those gains are worth having in their own right.
A number on a scale describes very little on its own. What follows is what a thorough assessment actually looks at.
| Measure | What it tells you | What it misses |
|---|---|---|
| Body mass index | A quick population-level screen, and the entry point for most clinical pathways | Cannot separate muscle from fat, says nothing about fat distribution, and thresholds perform differently across ethnic groups |
| Waist circumference | Abdominal fat, which carries most of the metabolic risk | Measurement technique varies, and it is affected by posture and breathing |
| Waist-to-height ratio | Abdominal fat scaled to body size, useful across a range of heights | Still an external proxy for what is happening inside |
| HbA1c and fasting glucose | Whether glucose handling has already been affected | Can be normal while insulin resistance is well established |
| Lipid panel and blood pressure | Cardiovascular risk that is treatable now, independent of weight | Single readings mislead; blood pressure needs repeating |
| Liver enzymes and imaging | Fatty liver, which frequently travels with obesity | Enzymes can be normal in significant steatosis; see the NAFLD guide |
| Sleep apnea screening | A common, treatable and frequently missed contributor to fatigue and blood pressure | Requires asking; it is rarely volunteered |
| Thyroid function | An uncommon but correctable contributor; see thyroid disorders | Rarely the whole explanation, and treating it alone seldom resolves weight |
Diet quality, protein and fibre adequacy, sleep, resistance training, and treating what is treatable
The evidence here is unusually clear, and unusually unglamorous.
This is the shortest supplement section on this site, and that is the finding rather than an omission.
| Supplement | What it is actually for | Typical range | Timing | Notes & cautions |
|---|---|---|---|---|
| Vitamin D3 | Correcting a documented deficiency, which is more common at higher body weight because vitamin D distributes into adipose tissue. It supports bone and immune function. | Test 25-OH-D first and set the dose with your clinician | With a fat-containing meal | Trials of vitamin D given for weight loss have not shown meaningful benefit11. Correct a deficiency because it is a deficiency, not as a weight strategy. Target 40 to 60 ng/mL, the Endocrine Society's preferred range, and retest at 3 months. |
| Viscous fibre (psyllium, glucomannan) | Satiety and glycaemic steadiness where dietary fibre is hard to reach from food alone. | 3 to 10 g per day, divided | With water, before meals | Increase slowly to avoid bloating. Take at least 2 hours apart from medication, since viscous fibre can reduce absorption. Anyone with a stricture or a history of bowel obstruction should not take bulking fibre without medical advice. |
| Protein powder (whey, casein or soy) | Reaching protein targets during weight loss, which helps preserve lean mass. Food first; this is a convenience, not an upgrade. | 20 to 40 g per serving as needed to reach intake from food plus supplement | Around resistance training or at the meal lowest in protein | Choose a product with a short ingredient list. Anyone with reduced kidney function should agree protein intake with their clinician, since the right target differs; see chronic kidney disease. |
| Creatine monohydrate | Supporting strength and lean mass alongside resistance training, which matters because weight loss costs muscle as well as fat. | 3 to 5 g per day | Any time, consistently | Well studied for strength, not for fat loss. Causes a small rise in scale weight from muscle water, which is worth expecting rather than misreading. Discuss with your clinician if you have kidney disease. |
Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.
Last reviewed 27 August 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.12 This page is nutrition education, not medical advice, and it does not replace your doctor. Nutrition does not treat obesity on its own, and nothing here is offered as an alternative to medication or surgery, both of which are legitimate treatments for a chronic condition with strong biological drivers. What nutrition education can do is help you understand the evidence well enough to have a better conversation with the clinician who does treat you.